| Platelet refractoriness SB Rajadhyaksha, PD Desai, AA Navkudkar Global Journal of Transfusion Medicine 4 (2), 140-147, 2019 | 11 | 2019 |
| High efficacy and excellent safety profile of Actalycabtagene autoleucel, a humanized CD19 CAR-T product in r/r B-cell malignancies: A phase II pivotal trial H Jain, A Karulkar, D Kalra, S Ravikumar, N Ghandade, R Patil, S Shah, ... Blood 142, 4838, 2023 | 8 | 2023 |
| On-site and off-site adverse donor reactions in voluntary whole blood donors: A study from a tertiary care oncology center PD Desai, AA Navkudkar, SB Rajadhyaksha Global Journal of Transfusion Medicine 4 (1), 28-32, 2019 | 8 | 2019 |
| Therapeutic leukocyte reduction for acute and chronic myeloid leukemias: A 4-year experience from an oncology center in India AA Tendulkar, PA Jain, A Gupta, N Sharma, A Navkudkar, V Patle Asian journal of transfusion science 11 (2), 156-161, 2017 | 8 | 2017 |
| Making anti-CD19 CAR-T cell therapy accessible and affordable: first-in-human phase I clinical trial experience from India A Karulkar, H Jain, S Shah, A Khan, A Jaiswal, A Firfiray, P Suvasia, ... Blood 140 (Supplement 1), 4610-4611, 2022 | 7 | 2022 |
| Effect of citrate on ionized calcium levels during plateletpheresis procedures A Navkudkar, P Desai, S Rajadhyaksha ISBT Science Series 16 (1), 26-30, 2021 | 7 | 2021 |
| Phase I trial of humanized CD19 CART-cell therapy developed in India: safe, active and feasible for outpatient therapy H Jain, A Karulkar, N Sharma, M Sengar, A Jaiswal, S Shah, A Khan, ... Blood 140 (Supplement 1), 10332-10334, 2022 | 5 | 2022 |
| Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a … P Desai, P Sontakke, S Rajadhyaksha, A Navkudkar Transfusion and Apheresis Science 59 (5), 102842, 2020 | 5 | 2020 |
| ABO blood group discrepancies in blood donor and patient samples at a tertiary care oncology centre: Analysis and serological resolution P Desai, A Navkudkar, S Rajadhyaksha Hematology, Transfusion and Cell Therapy 46 (4), 402-407, 2024 | 4 | 2024 |
| Management of transfusion needs in a case of immunizing anti-M antibody in a patient with acute myeloid leukemia A Navkudkar, P Desai, R Thakkar, S Rajadhyaksha Indian Journal of Pathology and Microbiology 63 (2), 251-254, 2020 | 4 | 2020 |
| Post-donation telephonic interview: A tool for active follow-up of voluntary whole blood donors for analysis of frequency and predisposing factors of adverse reactions A Navkudkar, P Desai, S Rajadhakshaya Indian Journal of Medical Sciences 73 (3), 317-322, 2021 | 3 | 2021 |
| Evaluation of utilization pattern of fresh frozen plasma in a tertiary care oncology center P Desai, A Navkudkar, SB Rajadhyaksha Global Journal of Transfusion Medicine 3 (2), 109-112, 2018 | 3 | 2018 |
| Unexpected high platelet counts in a potential platelet donor: A clue to essential thrombocythemia A Navkudkar, P Desai, S Rajadhyaksha Asian Journal of Transfusion Science 14 (1), 87-89, 2020 | 2 | 2020 |
| Navigating the neutropenic abyss with granulocyte transfusions: Retrospective single‐center analysis of effectiveness and safety in India P Desai, A Navkudkar, B Bagal, C Dhamne, H Jain, M Sengar, ... Journal of Clinical Apheresis 38 (6), 703-710, 2023 | 1 | 2023 |
| Does granulocyte transfusion help pediatric cancer patients with sepsis? S Keerthivasagam, S Srinivasan, A Navkudkar, A Chichra, NR Moulik, ... Pediatric Blood & Cancer 70 (9), e30547, 2023 | 1 | 2023 |
| Evaluation of Appropriateness of Red Blood Cell Transfusions: A Prospective Audit at a Tertiary Care Oncology Centre P Desai, A Navkudkar, N More, SB Rajadhyaksha Global Journal of Transfusion Medicine 8 (1), 34-39, 2023 | 1 | 2023 |
| Epitope matched platelets: An effective way to provide platelet transfusion support in platelet refractory patients in a tertiary care oncology centre A Navkudkar, J Rajak, M Tambe, S Rajadhyaksha, M Singh J Blood Lymph 8 (217), 2, 2018 | 1 | 2018 |
| Talicabtagene Autoleucel (humanized CD19 CAR-T) As a Second Line Therapy in r/r B-Cell Lymphoma: Sub-Analysis from a Phase I/II Trial H Jain, A Karulkar, AK Jaiswal, D Kalra, S Ravikumar, S Shah, A Firfiray, ... Blood 144, 7203, 2024 | | 2024 |
| Real World Data of Novel Talicabtagene Autoleucel (humanized CD19 CAR-T) from India; Ensuring Equitable Access with Excellent Safety and Efficacy Profile H Jain, A Karulkar, D Kalra, S Ravikumar, S Shah, A Firfiray, J Pendhari, ... Blood 144, 3755, 2024 | | 2024 |
| Transfusion Medicine in Oncology P Desai, A Navkudkar, S Rajadhyaksha Tata Memorial Centre Textbook of Oncology, 181-187, 2024 | | 2024 |
